今日观察！A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.

《中国奇谭》第二季蓄势待发 国创动漫IP再添新机遇

备受好评的国产动画集《中国奇谭》第一季落下帷幕，但“中国小妖怪”的故事却远未结束。近日，哔哩哔哩与上海电影美术制片厂联合宣布，《中国奇谭》第二季正式启动，并同步公布了68部国创动画作品。这不仅为喜爱《中国奇谭》的观众带来了福音，也为中国动漫IP的开发和运营注入了新的活力。

**《中国奇谭》第一季的成功，展现了中国动画的独特魅力和广阔发展前景。**该片以单元剧的形式，讲述了八个根植于中国传统文化的独立故事，风格各异，引人入胜。无论是充满童趣的《小妖怪的夏天》，还是意蕴深远的《小满》，都展现了中国动画人丰富的想象力和精湛的创作功底。该片在国内外收获了广泛好评，在哔哩哔哩平台的评分高达9.9分，豆瓣评分也达到9.5分，成为近年来最受关注的国产动画作品之一。

**《中国奇谭》第二季的启动，标志着上海电影美术制片厂和哔哩哔哩在国创动漫领域的强强合作。**上海电影美术制片厂是中国动画的摇篮，曾创作了《大闹天宫》《哪吒闹海》等众多经典动画作品。哔哩哔哩则是国内领先的视频网站，拥有大量的年轻用户群体和丰富的二次元文化资源。双方的合作将为《中国奇谭》第二季的创作和推广提供强有力的支持。

**《中国奇谭》第二季的开发，也将为中国动漫IP的开发和运营提供新的经验和启示。**近年来，随着中国动漫产业的快速发展，动漫IP的价值也越来越受到重视。然而，许多动漫IP在开发和运营方面都存在着不足，导致IP价值难以充分释放。《中国奇谭》第一季的成功，为动漫IP的开发和运营提供了宝贵的经验。该片以优秀的创作内容为基础，通过多元化的运营方式，成功打造了具有广泛影响力的动漫IP。

**《中国奇谭》第二季的启动，是上海电影美术制片厂和哔哩哔哩对中国动漫产业发展的信心和决心。**相信在双方的共同努力下，《中国奇谭》第二季将取得更加辉煌的成绩，并为中国动漫IP的开发和运营提供新的思路和范式。